Insiders · PCSA

PCSA insider transactions

Processa Pharmaceuticals Inc. (PCSA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

PCSA insiders

Everyone who has filed a Form 4 or 5 at Processa Pharmaceuticals Inc., latest first. Follow anyone to get their next filing.

• George K NgChief Executive Officer, Director+$135K
• Sheila GujrathiDirector
• Justin W YorkeDirector+$31.4K-$208K
• Russell SkibstedChief Financial Officer+$41.7K
• Geraldine PannuDirector+$5,253
• James R NealDirector+$2,000
• Patrick LinChief Business - Strategy Off+$161K
• Wendy GuyChief Administrative Officer+$32.9K
• Khoso BaluchDirector+$5,752
• David YoungPres. Research & Development, Director, 10% owner+$382K
• Sian BigoraChief Development Officer+$21.4K
• James H StankerChief Financial Officer+$6,810
• Virgil ThompsonDirector
• Robert Michael FloydOfficer+$14.1K
• Khalid IslamDirector
• James E Besser10% owner-$10.3M

Recent Form 3, 4, and 5 filings for PCSA

• 87d
  Chief Executive Officer Ng George K converted options into 1,600 shares, increasing direct ownership by 10% to 17,092 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 98d
  SEC Form 4 filed by Director Gujrathi Sheila

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 98d
  SEC Form 3 filed by new insider Gujrathi Sheila

  3 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Director Yorke Justin W

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Chief Financial Officer Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Director Pannu Geraldine

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Chief Executive Officer Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Director Neal James R

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Chief Business - Strategy Off Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Chief Administrative Officer Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 101d
  SEC Form 4 filed by Director Baluch Khoso

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 128d
  Chief Administrative Officer Guy Wendy bought $4,701 worth of shares (2,436 units at $1.93), increasing direct ownership by 20% to 14,394 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 128d
  Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (2,106 units at $1.93), increasing direct ownership by 19% to 13,113 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 128d
  Chief Executive Officer Ng George K bought $5,900 worth of shares (3,057 units at $1.93), increasing direct ownership by 25% to 15,492 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 128d
  Chief Financial Officer Skibsted Russell bought $6,325 worth of shares (3,277 units at $1.93), increasing direct ownership by 24% to 16,689 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 128d
  Pres. Research & Development Young David bought $4,885 worth of shares (2,531 units at $1.93), increasing direct ownership by 13% to 21,729 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 129d
  Director Yorke Justin W converted options into 203 shares, increasing direct ownership by 135% to 353 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 129d
  Director Pannu Geraldine converted options into 203 shares, increasing direct ownership by 9% to 2,391 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 129d
  Director Neal James R converted options into 203 shares, increasing direct ownership by 25% to 1,021 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 129d
  Director Baluch Khoso converted options into 203 shares, increasing direct ownership by 9% to 2,528 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 143d
  Pres. Research & Development Young David bought $4,589 worth of shares (2,067 units at $2.22), increasing direct ownership by 12% to 19,198 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 143d
  Chief Financial Officer Skibsted Russell bought $5,892 worth of shares (2,654 units at $2.22), increasing direct ownership by 25% to 13,412 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 143d
  Chief Executive Officer Ng George K bought $5,472 worth of shares (2,465 units at $2.22), increasing direct ownership by 25% to 12,435 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 143d
  Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (1,831 units at $2.22), increasing direct ownership by 20% to 11,007 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 143d
  Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (2,118 units at $2.22), increasing direct ownership by 22% to 11,958 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 158d
  Pres. Research & Development Young David bought $4,590 worth of shares (1,786 units at $2.57), increasing direct ownership by 12% to 17,131 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 158d
  Chief Financial Officer Skibsted Russell bought $5,890 worth of shares (2,292 units at $2.57), increasing direct ownership by 27% to 10,758 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 158d
  Chief Executive Officer Ng George K bought $5,472 worth of shares (2,129 units at $2.57), increasing direct ownership by 27% to 9,970 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 158d
  Chief Business - Strategy Off Lin Patrick bought $4,066 worth of shares (1,582 units at $2.57), increasing direct ownership by 21% to 9,176 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 158d
  Chief Administrative Officer Guy Wendy bought $4,701 worth of shares (1,829 units at $2.57), increasing direct ownership by 23% to 9,840 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 171d
  Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 31% to 7,841 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 171d
  Pres. Research & Development Young David bought $4,589 worth of shares (1,545 units at $2.97), increasing direct ownership by 11% to 15,345 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 171d
  Chief Business - Strategy Off Lin Patrick bought $4,066 worth of shares (1,369 units at $2.97), increasing direct ownership by 22% to 7,594 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 171d
  Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (1,583 units at $2.97), increasing direct ownership by 25% to 8,011 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 171d
  Chief Financial Officer Skibsted Russell bought $5,892 worth of shares (1,984 units at $2.97), increasing direct ownership by 31% to 8,466 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 171d
  Amendment: Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 86% to 3,979 units (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 171d
  Amendment: Chief Development Officer Bigora Sian bought $5,341 worth of shares (1,971 units at $2.71), increasing direct ownership by 36% to 7,481 units (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 189d
  Pres. Research & Development Young David bought $4,589 worth of shares (1,706 units at $2.69), increasing direct ownership by 14% to 13,813 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 189d
  Chief Financial Officer Skibsted Russell bought $5,891 worth of shares (2,190 units at $2.69), increasing direct ownership by 51% to 6,498 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 189d
  Chief Executive Officer Ng George K bought $5,471 worth of shares (2,034 units at $2.69), increasing direct ownership by 51% to 6,013 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 189d
  Chief Business - Strategy Off Lin Patrick bought $4,065 worth of shares (1,511 units at $2.69), increasing direct ownership by 32% to 6,236 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 189d
  Chief Administrative Officer Guy Wendy bought $4,702 worth of shares (1,748 units at $2.69), increasing direct ownership by 37% to 6,441 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 189d
  Chief Development Officer Bigora Sian bought $5,342 worth of shares (1,986 units at $2.69), increasing direct ownership by 36% to 7,496 units (SEC Form 4)

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 190d
  Amendment: Chief Executive Officer Ng George K bought $5,415 worth of shares (2,136 units at $2.54) (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 190d
  Amendment: Chief Executive Officer Ng George K bought $5,474 worth of shares (1,843 units at $2.97), increasing direct ownership by 86% to 3,979 units (SEC Form 4)

  4/A - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 203d
  SEC Form 4 filed by Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 203d
  SEC Form 4 filed by Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 203d
  SEC Form 4 filed by Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 203d
  SEC Form 4 filed by Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 203d
  SEC Form 4 filed by Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 203d
  SEC Form 4 filed by Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 218d
  SEC Form 4 filed by Neal James R

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Young David

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Skibsted Russell

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Pannu Geraldine

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Ng George K

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Lin Patrick

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Guy Wendy

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Bigora Sian

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)
• 219d
  SEC Form 4 filed by Baluch Khoso

  4 - Processa Pharmaceuticals, Inc. (0001533743) (Issuer)